← Leaderboards
Jason Bini
Yale University
$1,784,099
Attributed
$1,784,099
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $768.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,784,099 · 3
By mechanism
K01$847,653 · 1
R01$768,946 · 1
R03$167,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Nancy H Ruddle$6,951,769
- Patrick G Gallagher$20,192,607
- Terril L Verplaetse$2,459,325
- Jaime Grutzendler$24,021,025
- Tae Hoon Kim$2,072,175
Others in their field
Other Emerging Leaders on “Pancreas”
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$6,921,511
- Kian H Lim · Washington University$6,890,308
- Kyle Jeffrie Gaulton · University Of California, San Diego$6,762,817
- Yi Ye · New York University$6,186,890
- William Andrew Daunch · Focal Medical, Inc.$6,182,545
- Julie Beth Sneddon · University Of California, San Francisco$5,761,571
Research focus
PancreasMeasurementUptakeCommunitiesRadioligandPositron-Emission TomographyInsulin SecretionInsulinNon-DiabeticProgramsEffective TherapyQuality Of LifeSocietiesResponseAwardAffectGlucoseBindingIn VivoReportingTissuesBrainFunctional DisorderPublishing
Grant awards (8)
Longitudinal PET/MRI assessment of the pancreas in individuals at risk for and with recent onset type 1 diabetes$768,946
R01 · FY2025 · DK · contact PI
Positron emission tomography to characterize beta cell mass in individuals from multiple stages in the progression of type 1 diabetes$167,500
R03 · FY2023 · DK · contact PI
Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand$153,846
K01 · FY2023 · DK · contact PI
Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand$76,923
K01 · FY2023 · DK · contact PI
Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand$153,846
K01 · FY2022 · DK · contact PI
Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand$153,846
K01 · FY2021 · DK · contact PI
Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand$153,846
K01 · FY2020 · DK · contact PI
Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand$155,346
K01 · FY2019 · DK · contact PI